93 related articles for article (PubMed ID: 9792304)
1. IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases.
Hernández JM; Gutiérrez NC; Almeida J; García JL; Sánchez MA; Mateo G; Ríos A; San Miguel JF
Br J Haematol; 1998 Oct; 103(1):163-7. PubMed ID: 9792304
[TBL] [Abstract][Full Text] [Related]
2. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis.
Laï JL; Zandecki M; Mary JY; Bernardi F; Izydorczyk V; Flactif M; Morel P; Jouet JP; Bauters F; Facon T
Blood; 1995 May; 85(9):2490-7. PubMed ID: 7537117
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques.
Smadja NV; Louvet C; Isnard F; Dutel JL; Grange MJ; Varette C; Krulik M
Br J Haematol; 1995 Jul; 90(3):619-24. PubMed ID: 7647003
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method.
Brigaudeau C; Trimoreau F; Gachard N; Rouzier E; Jaccard A; Bordessoule D; Praloran V
Br J Haematol; 1997 Mar; 96(3):594-600. PubMed ID: 9054668
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in thirty-four patients.
Cuneo A; Balsamo R; Roberti MG; Bardi A; Piva N; Balboni M; Bigoni R; Rigolin GM; Castoldi G
Cancer Genet Cytogenet; 1996 Sep; 90(2):171-5. PubMed ID: 8830729
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation.
Nilsson T; Lenhoff S; Turesson I; Rylander L; Mitelman F; Westin J; Höglund M; Johansson B
Eur J Haematol; 2002 Jun; 68(6):345-53. PubMed ID: 12225392
[TBL] [Abstract][Full Text] [Related]
7. C-kit ligand (SCF) in human multiple myeloma cells.
Lemoli RM; Fortuna A
Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
[TBL] [Abstract][Full Text] [Related]
8. [The cytogenetic and molecular genetic study of 81 multiple myeloma patients].
Li JT; Chang NB; Liu H; Pei L
Zhonghua Nei Ke Za Zhi; 2011 Dec; 50(12):1039-42. PubMed ID: 22333174
[TBL] [Abstract][Full Text] [Related]
9. Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients.
Facon T; Lai JL; Nataf E; Preudhomme C; Zandecki M; Hammad M; Wattel E; Jouet JP; Bauters F
Br J Haematol; 1993 Aug; 84(4):743-5. PubMed ID: 8217836
[TBL] [Abstract][Full Text] [Related]
10. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of mouse granulocytes and macrophages produced in vitro from bone marrow progenitors stimulated with interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF).
Bender JG; Unverzagt KL; Maples PB; Mehrotra Y; Mellon J; Van Epps DE; Stewart CC
Exp Hematol; 1992 Oct; 20(9):1135-40. PubMed ID: 1361455
[TBL] [Abstract][Full Text] [Related]
12. Colony-stimulating activity in the serum of patients with hemopoietic malignancies after intensive chemotherapy/radiotherapy: its augmentation by GM-CSF in vivo and interleukin 4 in vitro.
Millar BC; Bell JB; Millar JL; Treleaven J; Montes A; Joffe JK; Powles RL; McElwain TJ
Exp Hematol; 1992 Feb; 20(2):209-15. PubMed ID: 1371966
[TBL] [Abstract][Full Text] [Related]
13. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
Gazzola MV; Collins NH; Tafuri A; Keever CA
Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications.
Jelinek DF; Ahmann GJ; Greipp PR; Jalal SM; Westendorf JJ; Katzmann JA; Kyle RA; Lust JA
Cancer Res; 1993 Nov; 53(21):5320-7. PubMed ID: 8221668
[TBL] [Abstract][Full Text] [Related]
15. Production of granulocyte colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor after interleukin-1 stimulation of marrow stromal cell cultures from normal or aplastic anemia donors.
Migliaccio AR; Migliaccio G; Adamson JW; Torok-Storb B
J Cell Physiol; 1992 Jul; 152(1):199-206. PubMed ID: 1377699
[TBL] [Abstract][Full Text] [Related]
16. Suppression of chronic myelogenous leukemia colony growth by interleukin-4.
Estrov Z; Markowitz AB; Kurzrock R; Wetzler M; Kantarjian HM; Ferrajoli A; Gutterman JU; Talpaz M
Leukemia; 1993 Feb; 7(2):214-20. PubMed ID: 8426475
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic studies of non-lymphocytic neoplasias using hematopoietic growth factors: GM-CSF provides pronounced mitotic increase and improvement of the quality of banded chromosomes compared to G-CSF.
Nakamura H; Sasagawa I; Itoyama T; Mine M; Amenomori T; Sadamori N; Tomonaga M
Leukemia; 1993 Sep; 7(9):1471-5. PubMed ID: 7690442
[TBL] [Abstract][Full Text] [Related]
18. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
19. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors.
Van den Berg E; Van Oven MW; de Jong B; Dam A; Wiersema J; Dijkhuizen T; Hoekstra HJ; Molenaar WM
Lab Invest; 1994 Mar; 70(3):307-13. PubMed ID: 8145525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
